CADPS anticorps (AA 151-250)

N° du produit ABIN1385753

Détail du produit anti-CADPS anticorps

Antigène: CADPS (Ca++-Dependent Secretion Activator (CADPS))

Épitope: AA 151-250

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CADPS est non-conjugé

Application: Immunohistochemistry (Frozen Sections) (IHC (fro))

Homologie: Human,Mouse,Rat,Dog,Cow,Sheep,Pig,Horse,Chicken

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human CAPS1

Isotype: IgG

Information d'application

Indications d'application: IHC-F 1:100-500

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Date de péremption: 12 months

Détails sur CADPS

Antigène: CADPS (Ca++-Dependent Secretion Activator (CADPS))

Autre désignation: CAPS1 (CADPS Produits)

Synonymes: anticorps CADPS1, anticorps CAPS, anticorps CAPS1, anticorps Caps, anticorps Caps1, anticorps Caps2, anticorps AU067781, anticorps mKIAA1121, anticorps CADPS, anticorps cadps, anticorps MGC122552, anticorps CAPS-1, anticorps caps, anticorps caps1, anticorps si:busm1-1i3.1, anticorps si:busm1-6a2.7, anticorps si:dz6a2.7, anticorps calcium dependent secretion activator, anticorps Ca2+-dependent secretion activator, anticorps Ca2+-dependent activator protein for secretion b, anticorps Ca2+ dependent secretion activator, anticorps Ca2+ dependent secretion activator L homeolog, anticorps Ca2+-dependent activator protein for secretion a, anticorps CADPS, anticorps Cadps, anticorps cadpsb, anticorps cadps, anticorps cadps.L, anticorps cadpsa

Sujet:

Synonyms: Cadps, CADPS1, Calcium dependent secretion activator 1, Calcium-dependent activator protein for secretion 1, Calcium-dependent secretion activator 1, Caps, CAPS-1, rCAPS, CAPS1_HUMAN.

Background: Calcium-dependent secretion activators (CAPS-1 and CAPS-2) are calcium-binding proteins that direct neurotransmitter and neuropeptide-filled vesicles to the cell membrane for secretory granule exocytosis. Both CAPS-1 and CAPS-2 are expressed primarily in the brain where they regulate the secretion of various substances. The CAPS proteins contain a PH domain that is essential for regulation of exocytosis, as well as regulation of phospholipid binding. Through their regulation of neurotrophin release from granule cells, CAPS proteins help to regulate cell fate during neuronal development. CAPS-1 is thought to regulate catecholamine release from neuronal cells, while CAPS-2 is thought to regulate release of both brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) from granule cells. Defects in the genes encoding CAPS-1 and CAPS-2 are implicated in impaired cerebral development and autism.

Pathways: Synaptic Vesicle Exocytosis